Nicox to participate at two upcoming investor conferences
Tweet
Share
E-mail| Nicox to participate at two upcoming investor conferences March 1, 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, today announced that members of the management team will participate in the following investor conferences in March 2017 in the United States: Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7 at 9:20 a.m. ET at the Boston Marriott Copley Place in Boston. The presentation will be available on Nicox website (www.nicox.com) in "Presentations & Events". Oppenheimer 27th Annual Healthcare Conference on Wednesday, March 22 at 8:35 a.m. ET at the Westin Grand Central Hotel in New York. A live webcast of the presentation will be available on Nicox website (www.nicox.com) in "Presentations & Events". A replay of the webcast will be archived for 90 days following the date of the presentation. Members of the management team will also be available for one-on-one meetings at the conferences. | |
| About Nicox | |
| Nicox is an international ophthalmic R&D company utilizing innovative science to maintain vision and improve ocular health. By leveraging its proprietary expertise in nitric oxide donation and other technologies, the Company is developing an extensive portfolio of novel therapies that target multiple ophthalmic conditions, including glaucoma. Nicox currently has two products at the pre-approval stage with the U.S. Food and Drug Administration (FDA) and a promising pipeline including next-generation stand-alone nitric-oxide donors, with the potential to treat a range of ophthalmic indications. Nicox is headquartered in Sophia Antipolis, France, is listed on Euronext Paris (Compartment B: Mid Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. For more information on Nicox, its products or pipeline, please visit: www.nicox.com . | |
| Analyst coverage | |
| Bryan, Garnier & Co Hugo Solvet Paris, FranceInvest Securities Martial Descoutures Paris, FranceGilbert Dupont Damien Choplain Paris, France Stifel Olivia Manser London, UK | |
| Upcoming financial and business conferences | |
| April 4-5 Needham's 16th Annual Healthcare Conference New York, USApril 18-19 Small Cap Event Paris, France May 3-4 Deutsche Bank 42nd Annual Health Care Conference Boston, USMay 22-23 BioEquity Europe Paris, France May 30 Gilbert Dupont 15th Annual Healthcare Conference Paris, France June 19-22 2017 BIO International Convention San Diego, US | |
| Contacts | |
| NicoxGavin Spencer,Executive Vice President Corporate Development T +33 (0)4 97 24 53 00[email protected] | |
| Investor RelationsEurope NewCap Julien Perez, Valentine BrouchotT +33 (0)1 44 71 94 94[email protected] | Media Relations United Kingdom Jonathan BirtT +44 7860 361 746[email protected] |
| United States Argot Partners Melissa ForstT +1 (212) 600-1902[email protected] | France NewCapNicolas MerigeauT +33 (0)1 44 71 94 98[email protected] |
| United States Argot Partners Eliza SchleifsteinT +1 (917) 763-8106[email protected] | |
| Disclaimer | |
| The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements. | |
| Nicox S.A.Drakkar 2 Bât D, 2405 route des Dolines CS 10313, Sophia Antipolis 06560 Valbonne, France T +33 (0)4 97 24 53 00 F +33 (0)4 97 24 53 99 | |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Sanctuary Expands to Six Charlotte-Area Senior Care Residences
- Ethereum Price Prediction: Can ETH Reach $3,050 as Remittix Targets Its $0.46 Final Stage?
- Best Crypto Presale: Bitcoin Hits an Eight-Month High as Remittix Confirms Its Official Token Launch Date
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Stifel, Deutsche Bank, Needham & Company, Cowen & Co, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
